Merck swings to 3q loss on big charge, raises forecast
Businessam Staff
October 27, 2017
Lower sales for multiple medicines and a whopping charge for a big cancer drug collaboration drove Merck & Co. to a third-quarter
- FRONTPAGE
- FINANCE
- AllAsset ManagementAuditBankingBondBudgetCapital MarketsC&I LeasingCurrencyDealDebt marketForexFund RaisingFundingGovernmentHedge FundsInsuranceInvestmentInvestorInvestor ServicesMergers & AcquistionsMoney marketTreasury BillsMortgagePensionsPersonal financePonziQuantitative EasingshareTaxationTSAWealth Management
- MARKETS
- ECONOMY
- COMMODITIES
- ENERGY
- TECHNOLOGY
- MANUFACTURING
- ANALYSIS